Laura J. Tafe, MD, associate professor of pathology and laboratory medicine at Geisel School of Medicine at Dartmouth, and assistant director of the Laboratory for Clinical Genomics and Advanced Technologies, Dartmouth-Hitchcock Medical Center, discusses a case of ALK-rearranged lung cancer, which was the subject of a multidisciplinary molecular tumor board presented last fall at the annual CAP meeting.
http://www.captodayonline.com/molecular-tumor-board-patient-alk-rearranged-lung-cancer/
